Literature DB >> 25289117

Curcumin Stimulates Proliferation of Spinal Cord Neural Progenitor Cells via a Mitogen-Activated Protein Kinase Signaling Pathway.

Sihoon Son1, Kyoung-Tae Kim1, Dae-Chul Cho1, Hye-Jeong Kim1, Joo-Kyung Sung1, Jae-Sung Bae2.   

Abstract

OBJECTIVE: The aims of our study are to evaluate the effect of curcumin on spinal cord neural progenitor cell (SC-NPC) proliferation and to clarify the mechanisms of mitogen-activated protein (MAP) kinase signaling pathways in SC-NPCs.
METHODS: We established cultures of SC-NPCs, extracted from the spinal cord of Sprague-Dawley rats weighing 250 g to 350 g. We measured proliferation rates of SC-NPCs after curcumin treatment at different dosage. The immuno-blotting method was used to evaluate the MAP kinase signaling protein that contains extracellular signal-regulated kinases (ERKs), p38, c-Jun NH2-terminal kinases (JNKs) and β-actin as the control group.
RESULTS: Curcumin has a biphasic effect on SC-NPC proliferation. Lower dosage (0.1, 0.5, 1 µM) of curcumin increased SC-NPC proliferation. However, higher dosage decreased SC-NPC proliferation. Also, curcumin stimulates proliferation of SC-NPCs via the MAP kinase signaling pathway, especially involving the p-ERK and p-38 protein. The p-ERK protein and p38 protein levels varied depending on curcumin dosage (0.5 and 1 µM, p<0.05).
CONCLUSION: Curcumin can stimulate proliferation of SC-NPCs via ERKs and the p38 signaling pathway in low concentrations.

Entities:  

Keywords:  Curcumin; Mitogen activated protein kinase; Spinal cord neural progenitor cell

Year:  2014        PMID: 25289117      PMCID: PMC4185312          DOI: 10.3340/jkns.2014.56.1.1

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


INTRODUCTION

A neural progenitor cell (NPC) has the capability to divide, migrate and differentiate into neurons, and NPC proliferation is an important pathway in functional recovery after spinal cord injury (SCI)1,2). Cellular and molecular mechanisms have been studied to understand NPC proliferation31). Recently, mitogen-activated protein (MAP) kinase signaling pathways are among the most important mechanisms of NPC proliferation, and extracellular signal-regulated kinases (ERKs), p38 kinases and c-Jun NH2-terminal kinases (JNKs) are well known MAP kinases5,8,15,29). Curcumin (diferuloylmethane) is found in the rhizomes of the plant Curcuma longa Linn (tumeric). Traditionally, tumeric has been used as a dietary spice and as a treatment of diseases associated with injury and inflammation9,10). Curcumin has a diverse set of biologic effects, including anti-inflammatory and antioxidanteffects3,11,12,22). Recently, some studies suggest the possibility that curcumin could increase the proliferation of subventricular zone (SVZ) originated NPCs via a MAP kinase signaling pathway1,23,32). However, SVZ-NPCs and spinal cord NPCs (SC-NPCs) have some differences involving gene expression and proliferation characteristics. Liu et al.19) reported different electrophysiological properties of mitogen-expansion between adult rat SC-NPCs and SVZ-NPCs. Also, Pfenninger et al.27) reported different gene expressions and proliferations between adult spinal cord ependymal cells and SVZ originated neural precursor cells. Therefore, the objectives of this study are to evaluate the effect of curcumin on SC-NPC proliferation and to clarify the mechanisms of the MAP kinase signaling pathways in SC-NPCs.

MATERIALS AND METHODS

NPC cultures

To establish cultures of SC-NPCs, Sprague-Dawley rats weighting 250 g to 350 g were sacrificed and their spinal cords were extracted. The spinal cords were chopped using microscissors and incubated in a cocktail containing papain (0.1%, Worthington Biochemical Corp., Lakewood Township, NJ, USA), dispase (0.1%), DNase (0.01%), and MgSO4 (12.4%) in a Hanks balanced salt solution with glucose (0.45%) for 30 minutes at 37℃. The dissociated cells were cultured to form neurospheres in a neurobasal medium containing B-27, glutamin (2 mmol/L), penicillin/streptomycin (0.1 g/mL), fibroblast growth factor-2 (20 µg/mL), and heparin (2 µg/mL). Every 5 days, the neurospheres were dissociated with accutase and NPCs were plated into 96-well plates or culture dishes containing culture medium. The NPCs between 5 and 25 passages were used for the experiments.

NPC proliferation assay

The NPCs were suspended in 100 uL of a neurobasal medium containing curcumin and cultured in a 96-well plate. In different experiments, various concentrations of curcumin (0.1-50 µmol/L) were used. A 20-uL cell proliferation assay solution containing the tetrazolium compound MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-phenyl)-2H-tetrazolium), (CellTiter 96 Aqueous One Solution, Promega®, Fitchburg, WI, USA) was added to a well containing cultured cells and incubated for 2.5 hours (hrs) at 37℃. The optical density was measured at 490 nm with a microplate spectrophotometer. The same volume of culture medium with the assay solution was used as a blank. The optical density at 490 nm after reaction with MTS showed a proportional correlation to the number of cells. To study the effect of the duration of curcumin, cells were seeded at a density of 1×104 cells in 96-well plates. After 48 hrs, the cells were treated with different concentrations of curcumin (0.1, 0.5, 1, 10, 20, and 50 µM).

MAP kinase signaling pathway analysis

We used an immunoblotting method for evaluating the MAP kinase signaling protein. The protein concentration was mixed with a RIPA buffer (25 mM Tris-Cl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) containing a protease inhibitor cocktail (Roche®, Mannheim, Germany) and immediately homogenized. The homogenate was centrifuged at 13000 rpm for 30 min at 4℃ and the supernatants were determined using the BCA protein assay (Sigma®, St. Louis, MO, USA). Proteins were separated by a 10% SDS-PAGE gel and transferred to a nitrocellulose membrane. Incubation was in a blocking solution of 5% non-fat dry milk in Tris-buffered saline containing 0.1% Tween 20 for 1 hr at room temperature. The membrane was incubated with a 1 : 1000 dilution of mouse monoclonal phospho-ERK, phospho-p38, phospho-JNK (Santa Cruz®, CA, USA), β-actin (Sigma®, St. Louis, MO, USA) and mouse monoclonal anti-β-actin (Sigma Aldrich®, Saint Louis, MO, USA) overnight at 4℃, and then with a horseradish peroxidase-conjugated secondary antibody for 1 hr at room temperature. The proteins were detected with chemiluminescence reagents. Immune-positive bands used an image J, version 1.46 r, computer-assisted image analyzer (National Institutes of Health, Bethesda, MD, USA).

Statistical analysis

All statistical comparisons were computed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). Data are expressed as mean±standard error of the means. Repeated measure analysis of variance was used to compare groups. Null hypotheses of no difference were rejected if p-values were less than 0.05.

RESULTS

Curcumin increases the proliferation of SC-NPCs

To study that the effect of curcumin on the proliferation of SC-NPCs, SC-NPCs growing in 96-well plates were maintained in medium lacking or containing increased concentrations of curcumin, and the cell proliferation rate was quantified at different time points. After 48 hours of curcumin treatment, lower dosage (0.1, 0.5, 1 µM) of curcumin increased NPC proliferation, whereas high dosage (≥10 µM) caused a decrease in NPC proliferation (Fig. 1). The result shows a few percent improvement compared to each control group.
Fig. 1

Curcumin has biphasic effects on SC-NPC proliferation. The SC-NPC proliferation rate was quantified at different time points. After 48 hrs of curcumin treatment, lower curcumindosage (0.1, 0.5, 1 µM) increased NPC proliferation. But higher dosage (10, 20, 50 µM) of curcumin decreased the NPC proliferation rate. *Significantly increased compared with corresponding value for control group (p<0.05). SC-NPC : spinal cord neural progenitor cell.

To evaluate the neurosphere formation, dissociated SC-NPCs were diluted in a culture medium and plated into 96-well plate dishes and cultured for 48 hrs. The cells were treated with 1 µM curcumin for 24 hrs. NPC proliferation and neurosphere formation of the curcumin treated group (Fig. 2A) were increased compared to the control group (Fig. 2B).
Fig. 2

The images show that different cell proliferation between the control group and curcumin treated group. Microscopically, the curcumin treated group (A) had increased cell proliferation and neurosphere formation compared with the control group (B).

The proliferation of NPC via the MAP kinase pathway

We investigated curcumin treatment associated with MAP kinase signaling pathways, especially involving ERK, p38, and JNK proteins related to NPC proliferation19,29). Immunoblot analysis was used on antibodies against phospho-ERK (p-ERK), phospo-P38 (p-p38), and phosph-o-JNK (p-JNK), and levels of β-actin were determined as a control against possible protein loading variability. The p-ERK protein and p38 protein levels show increases depending on curcumin dosage (0.5, 1 µM, p<0.05), whereas p-JNK and β-actin protein levels show marginal differences without depending on curcumin dosage (Fig. 3).
Fig. 3

Curcumin stimulates proliferation of NPCs via the MAP kinase signaling pathway, and ERK and p38 proteins are connected with this MAP pathway. A : Immunoblot analysis was used by antibodies against phospho-ERK, phospo-p38, phospho-JNK. The phospho-ERK protein level increased with curcumin dosage of 0.5, 1 µM and the phospho-p38 protein level also showedanincrease. But phospho-JNK and β-actin protein levels show a marginal difference with curcumin dosage. Levels of β-actin were determined as a control against possible protein loading variability. B : Phospho-ERK and phospho-p38 protein levels increased via curcumin dosage-dependence (p<0.05). *Significant increased protein level compared with control group. NPC : neural progenitor cell, MAP : mitogen-activated protein, ERK : extracellular signal-regulated kinase, JNK : c-Jun NH2-terminal kinase.

DISCUSSION

SCI has been thought to be irreversible and the cause of critical sequela. Many studies have reported a desire to minimize secondary injury and increase functional recovery from neurological deficit16,17,21,30). Recently, NPC proliferation after SCI plays an important role in functional recovery from neurological dys-function18,26). This study finds that curcumin stimulates NPCs proliferation through a MAP kinase signaling pathway, and especially involves the ERK protein and the p38 protein. Also, the effect is biphasic in that low concentrations stimulated cell proliferation, while high concentrations inhibited it15,24,28,29). Previous studies have documented that curcumin could affect proliferation of stem cells through diverse pathways. Kim et al.13) found that a low concentration of curcumin stimulates proliferation and stemness acting signals of pre-adipocytes by the phosphoinositide 3-kinase pathway, whereas it inactivates p38 kinases and JNK protein. Mujoo et al.25) reported that curcumin induces differentiation of embryonic stem cells through nitric oxide-cyclic signaling. Kim et al.15) documented that curcumin stimulates proliferation of embryonic NPCs and neurogenesis in the adult hippocampus. The study suggested that a MAP kinase signaling pathway is connected to NPC proliferation through ERKs and the p38 protein. In the present study, we investigated the effect of curcumin on SC-NPCs and analyzed MAP kinase signaling. According to the results, SC-NPC proliferation increased with lower dosage (0.1, 0.5, 1 µM) of curcumin. But, higher dosage (10, 20, 50 µM) of curcumin decreased the NPC proliferation rate. These results are comparable with previous studies showing that curcumin stimulates NPC proliferation relative to the dosage15,28,29). Consequently, for effective clinical applications, these results suggest that proper dosage is important. Therefore, in future studies, we expect that setting the appropriate curcumin-dosage with human cells will be very important. We found that curcumin affects the proliferation of SC-NPCs, and likewise it affects SVZ-NPCs via the MAP kinase signaling pathway, as we analyzed MAP kinase proteins in this study. Especially, the MAP kinase signaling pathway was revealed as an important mechanism for most stem cell proliferation. There are many different types of MAP kinase and stem cells originated each organization was founded to have slightly different mechanism of MAP kinases5,8,15). Our findings are the first study to show that SC-NPCs are more relevant to ERK and p38 protein associated MAP kinases. The ERK protein has been reported to be concerned with cell proliferation, survival and apoptosis7), and the p38 protein played a vital role in cellular responses to external stress signals like anti-inflammatory reactions6). Anti-inflammatory effects might promote the proliferation of NPCs. Our finding suggests these effects are relevant to curcumin effect NPC proliferation. We consider that this result would be helpful to more selective agonists for NPC proliferation. However, this study has some limitations. First, this study involves only in-vitro experiments. The spinal cord is a complicated environment, so we need further in-vivo study to evaluate the curcumin effect in live tissue. Second, we used rat SC-NPCs in this experiment. The rat SC-NPC is different from the human SC-NPC, so the proper dosage could be different in humans.

CONCLUSION

This study suggests that curcumin stimulates NPCs proliferation through a MAP kinase signaling pathway, and especially involves the ERK protein and the p38 protein. Also, the effect is biphasic in that low concentrations stimulated cell proliferation, while high concentrations inhibited it. In future studies, we should evaluate the effect of curcumin and MAP kinase signaling in a SCI model.
  32 in total

1.  An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis.

Authors:  Catherine Ménard; Paul Hein; Annie Paquin; Aviva Savelson; Xiu Ming Yang; Doron Lederfein; Fanie Barnabé-Heider; Alain A Mir; Esta Sterneck; Alan C Peterson; Peter F Johnson; Charles Vinson; Freda D Miller
Journal:  Neuron       Date:  2002-11-14       Impact factor: 17.173

Review 2.  MAPK signaling pathways in the regulation of hematopoiesis.

Authors:  Christian R Geest; Paul J Coffer
Journal:  J Leukoc Biol       Date:  2009-06-04       Impact factor: 4.962

Review 3.  p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies.

Authors:  Rahul P Gangwal; Anuseema Bhadauriya; Mangesh V Damre; Gaurao V Dhoke; Abhay T Sangamwar
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

4.  Neuroprotective effect of curcumin on spinal cord in rabbit model with ischemia/reperfusion.

Authors:  Zhi-Qiang Liu; Shan-Shan Xing; Wei Zhang
Journal:  J Spinal Cord Med       Date:  2013-03       Impact factor: 1.985

Review 5.  Traditional Indian systems of medicine.

Authors:  R Lodha; A Bagga
Journal:  Ann Acad Med Singapore       Date:  2000-01       Impact factor: 2.473

Review 6.  Repair therapies in spinal cord injuries.

Authors:  Piotr Tederko; Marek Krasuski; Jerzy Kiwerski; Izabela Nyka; Dariusz Białoszewski
Journal:  Ortop Traumatol Rehabil       Date:  2009 May-Jun

Review 7.  Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.

Authors:  Vittorio Calabrese; D Allan Butterfield; Anna M Giuffrida Stella
Journal:  Ital J Biochem       Date:  2003-12

Review 8.  Molecular mechanisms of curcumin action: signal transduction.

Authors:  Adeeb Shehzad; Young Sup Lee
Journal:  Biofactors       Date:  2013-01-10       Impact factor: 6.113

Review 9.  Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment.

Authors:  Purusotam Basnet; Natasa Skalko-Basnet
Journal:  Molecules       Date:  2011-06-03       Impact factor: 4.411

Review 10.  Cell transplantation for spinal cord injury: a systematic review.

Authors:  Jun Li; Guilherme Lepski
Journal:  Biomed Res Int       Date:  2013-01-15       Impact factor: 3.411

View more
  10 in total

1.  Low-dose curcumin stimulates proliferation of rat embryonic neural stem cells through glucocorticoid receptor and STAT3.

Authors:  Xiao-Xiao Ma; Jin Liu; Chun-Man Wang; Jiang-Ping Zhou; Zhen-Zhou He; Han Lin
Journal:  CNS Neurosci Ther       Date:  2018-03-12       Impact factor: 5.243

2.  Methylglyoxal Causes Cell Death in Neural Progenitor Cells and Impairs Adult Hippocampal Neurogenesis.

Authors:  Hye Jeong Chun; Yujeong Lee; Ah Hyun Kim; Jaewon Lee
Journal:  Neurotox Res       Date:  2015-12-21       Impact factor: 3.911

3.  Curcumin as a Promising Neuroprotective Agent for the Treatment of Spinal Cord Injury: A Review of the Literature.

Authors:  Subum Lee; Dae-Chul Cho; Inbo Han; Kyoung-Tae Kim
Journal:  Neurospine       Date:  2022-06-30

4.  Curcumin as a double-edged sword for stem cells: dose, time and cell type-specific responses to curcumin.

Authors:  Fatemeh Attari; Maryam Zahmatkesh; Hadi Aligholi; Shahram Ejtemaei Mehr; Mohammad Sharifzadeh; Ali Gorji; Tahmineh Mokhtari; Mojtaba Khaksarian; Gholamreza Hassanzadeh
Journal:  Daru       Date:  2015-06-12       Impact factor: 3.117

5.  Curcumin Increase the Expression of Neural Stem/Progenitor Cells and Improves Functional Recovery after Spinal Cord Injury.

Authors:  Woo-Seok Bang; Kyoung-Tae Kim; Ye Jin Seo; Dae-Chul Cho; Joo-Kyung Sung; Chi Heon Kim
Journal:  J Korean Neurosurg Soc       Date:  2017-12-29

Review 6.  Traditional Chinese Medicine Monomers: Novel Strategy for Endogenous Neural Stem Cells Activation After Stroke.

Authors:  Ju Wang; Jun Hu; Xuezhu Chen; Xuejiao Lei; Hua Feng; Feng Wan; Liang Tan
Journal:  Front Cell Neurosci       Date:  2021-02-26       Impact factor: 5.505

Review 7.  The Potential of Curcumin in Treatment of Spinal Cord Injury.

Authors:  Raghavendra Sanivarapu; Vijayalakshmi Vallabhaneni; Vivek Verma
Journal:  Neurol Res Int       Date:  2016-05-19

8.  Investigating the use of curcumin-loaded electrospun filaments for soft tissue repair applications.

Authors:  Pierre-Alexis Mouthuy; Maja Somogyi Škoc; Ana Čipak Gašparović; Lidija Milković; Andrew J Carr; Neven Žarković
Journal:  Int J Nanomedicine       Date:  2017-05-25

9.  Does combined therapy of curcumin and epigallocatechin gallate have a synergistic neuroprotective effect against spinal cord injury?

Authors:  Jiri Ruzicka; Lucia Machova Urdzikova; Barbora Svobodova; Anubhav G Amin; Kristyna Karova; Jana Dubisova; Kristyna Zaviskova; Sarka Kubinova; Meic Schmidt; Meena Jhanwar-Uniyal; Pavla Jendelova
Journal:  Neural Regen Res       Date:  2018-01       Impact factor: 5.135

Review 10.  Curcumin, Hormesis and the Nervous System.

Authors:  Maria Concetta Scuto; Cesare Mancuso; Barbara Tomasello; Maria Laura Ontario; Andrea Cavallaro; Francesco Frasca; Luigi Maiolino; Angela Trovato Salinaro; Edward J Calabrese; Vittorio Calabrese
Journal:  Nutrients       Date:  2019-10-10       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.